RNDr. Pavel Krejčí, Ph.D.
Head of the research group, Pavel Krejčí Research Group
Office: bldg. A19/231a
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5395 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 123
2022
-
4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta
Journal of bone and mineral research, year: 2022, volume: 37, edition: 4, DOI
-
A registry of achondroplasia: a 6-year experience from the Czechia and Slovak Republic
Orphanet Journal of Rare Diseases, year: 2022, volume: 17, edition: 1, DOI
-
Cilia kinases in skeletal development and homeostasis
Developmental dynamics, year: 2022, volume: 251, edition: 4, DOI
-
Expanding horizons of achondroplasia treatment: current options and future developments
Osteoarthritis and Cartilage, year: 2022, volume: 30, edition: 4, DOI
-
Intervertebral disc degeneration is rescued by TGFβ/BMP signaling modulation in an ex vivo filamin B mouse model
Bone research, year: 2022, volume: 10, edition: 1, DOI
-
LuminoCell: a versatile and affordable platform for real-time monitoring of luciferase-based reporters
Life science alliance, year: 2022, volume: 5, edition: 8, DOI
-
Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells
Frontiers in Cell and Developmental Biology, year: 2022, volume: 10, edition: February 2022, DOI
-
Nanodiamonds as traps for fibroblast growth factors: Parameters influencing the interaction
Carbon, year: 2022, volume: 195, edition: 15, DOI
-
熱安定性FGF2ポリペプチド及びその使用
Publisher: Japan Patent Office (JPO), state: Japan, patent's number: JP7131772, year: 2022
2021
-
An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice
Science Translational Medicine, year: 2021, volume: 13, edition: 592, DOI